Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Institute For Strategy & Competitiveness
  • About The Institute
  • Research Areas
    • Research Areas
      • Health Care
      • Competitiveness & Economic Development
      • Creating Shared Value
      • Strategy
      • CEO Leadership
      • Philanthropy
      • Environmental Quality
      • Antitrust & Competition Policy
      • Innovation & Innovative Capacity
      • Social Progress Index
  • Resources
    • Resources
      • Courses
      • Data
      • Events & Presentations
      • Frameworks
      • News
      • Publications
      • Video
  • Health Care
  • Competitiveness & Economic Development
  • Creating Shared Value
  • Strategy
  • About Michael Porter
HBS→ISC→
Health Care
  • Health Care
  • Value-Based Health Care
  • Health Care Courses
  • Fast Facts
→
Value-Based Health Care
  • Value-Based Health Care
  • Cases & Teaching Notes
  • Key Concepts
  • Key Stakeholders
  • Publications
  • Team
  • Work With Us
  • Presentations
→
Key Stakeholders
  • Key Stakeholders
  • Providers
  • Patients
  • Health Plans
  • Employers
  • Suppliers
  • Policymakers
→Suppliers
Health Care → Value-Based Health Care → Key Stakeholders →
Suppliers
×Key Stakeholders
  • Providers
  • Patients
  • Health Plans
  • Employers
  • Suppliers
  • Policymakers

Suppliers

Suppliers of medical products, technology, and services play vital roles in the value of health care delivery and innovation in health care practice. By increasing patient success rates and concentrating on long-term patient outcomes and costs, they will benefit from healthy and sustainable competition. Several leading suppliers  are refocusing their efforts to achieve value when they introduce new products and drugs. The move to paying for value will mean that the pricing methods used in the past are not sustainable and supplies must carefully examine the outcomes relative to cost for every new drug and device introduced.

 

Key Action Steps for Suppliers

  1.  
    Base strategies on creating unique value for patients
  2.  
    Focus on cycles of care rather than narrow product usage
  3.  
    Sell not just products, but provider and patient support
  4. Use evidence of long-term clinical outcomes and cost to demonstrate value compared to alternative therapies
  5. Conduct new types of long-term comparative studies in collaboration with providers and patients
  6. Increase the success rate instead of maximizing usage
  7. Target marketing and sales to minimize unnecessary or ineffective therapies
  8. Help providers to utilize products better and minimize errors
  9. Concentrate marketing efforts on value, not volume and discounts
  10. Support provider efforts to measure and improve results at the medical condition level
ǁ
Campus Map
Institute for Strategy & Competitiveness
Harvard Business School
Ludcke House
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.